$OFLX

Omega Flex, Inc.

No enriched coverage for $OFLX in the last 7 days.

No SEC Form 4 filings for $OFLX in the last 30 days.

Med

Omega Flex Stock Down 16% as Q1 Earnings Tumble Y/Y on High Costs

Omega Flex (OFLX) saw its stock decline 15.6% after reporting a significant drop in Q1 2026 earnings per share and net income, largely due to high raw material costs and increased operating expenses. Despite this, the company maintains a strong balance sheet and continues to pay dividends, focusing on product innovation and liquidity over the next year.

Tariffs and raw materials cut Omega Flex net income 41.8%

Omega Flex (NASDAQ: OFLX) reported a significant 41.8% decline in net income for Q1 2026, falling to $2.08 million from $3.57 million a year prior, largely due to increased raw material and tariff costs, and higher marketing and product enhancement expenses. Net sales remained relatively stable at $23.09 million, a slight 1% decrease from Q1 2025. The company is, however, making targeted investments in equipment and facilities to expand capacity and support future growth.

OFLX SEC Filings - Omega Flex 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Omega Flex (OFLX) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms. It features AI-powered summaries to highlight key points from these regulatory documents for investors. Recent filings detail CEO phantom stock awards, institutional ownership updates, and quarterly financial results for Q3 and Q2 2025.